Senti Biosciences Says Stockholders Approve Merger With ST NewCo; Approve Reverse Split Ratio Of 1-For-20 To 1-For-50
Senti Biosciences Files Prospectus Covering Resale Of Up To 25,555,024 Shares Of Common Stock Offered By The Selling Securityholders